In vivo antitumor activity of a novel sulfonamide, HMN-214, against human tumor xenografts in mice and the spectrum of cytotoxicity of its active metabolite, HMN-176
Biological role of adduct formation of the ruthenium(III) complex NAMI-A with serum albumin and serum transferrin
Quinolizidinyl derivatives of iminodibenzyl and phenothiazine as multidrug resistance modulators in ovarian cancer cells
Effect of novel benzoylphenylurea derivatives on DNA polymerase α activity using the synthesome-based in vitro model system
A study of a different dose-intense infusion schedule of phenylacetate in patients with recurrent primary brain tumors
Weekly regimen of irinotecan/docetaxel in previously treated non-small cell lung cancer patients and correlation with uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphism
Pharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D3 analogue, in a phase I study of patients with advanced malignancies
A randomized phase II evaluation of bryostatin-1 (NSC #339555) in persistent or recurrent squamous cell carcinoma of the cervix : A Gynecologic Oncology Group Study
Activity of weekly irinotecan (CPT-11) in patients with advanced non-small cell lung cancer pretreated with platinum and taxanes
A phase II study of rebeccamycin analog (NSC-655649) in metastatic renal cell cancer
A phase II study of topotecan in patients with anaplastic oligodendroglioma or anaplastic mixed oligoastrocytoma
An open label, non-comparative phase II study of topotecan as salvage treatment for patients with soft tissue sarcoma